{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T14:31:20Z","timestamp":1754145080932,"version":"3.41.2"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,16]]},"DOI":"10.7759\/cureus.88063","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T11:36:19Z","timestamp":1752665779000},"source":"Crossref","is-referenced-by-count":0,"title":["Safety, Tolerability, and Pregnancy Outcomes Following Gravibinan Administration in Women at Risk of Miscarriage: A Multi-institutional Retrospective Study"],"prefix":"10.7759","author":[{"given":"Khadija","family":"Bano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seema","family":"Muzammil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atfa","family":"Muzamil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khair-un-Nisa","family":"Nizam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naila","family":"Ehsan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahida","family":"Magsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Rasheed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atif A","family":"Hashmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000002899","article-title":"ACOG Practice Bulletin No. 200: Early Pregnancy Loss","volume":"132","year":"2018","unstructured":"ACOG Practice Bulletin No. 200. Early Pregnancy Loss. Obstet Gynecol. 2018, 132:e197-207. 10.1097\/AOG.0000000000002899","journal-title":"Obstet Gynecol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1055\/a-1895-9940","article-title":"Recurrent miscarriage: diagnostic and therapeutic procedures. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No.\u2009015\/050, May 2022)","volume":"83","author":"Toth B","year":"2023","unstructured":"Toth B, Bohlmann M, Hancke K, et al.. Recurrent miscarriage: diagnostic and therapeutic procedures. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No.\u2009015\/050, May 2022). Geburtshilfe Frauenheilkd. 2023, 83:49-78. 10.1055\/a-1895-9940","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232214138","article-title":"Progesterone: the key factor of the beginning of life","volume":"23","author":"Bulletti C","year":"2022","unstructured":"Bulletti C, Bulletti FM, Sciorio R, Guido M. Progesterone: the key factor of the beginning of life. Int J Mol Sci. 2022, 23:10.3390\/ijms232214138","journal-title":"Int J Mol Sci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2018.1564742","article-title":"Steroid hormones and pregnancy","volume":"35","author":"Noyola-Mart\u00ednez N","year":"2019","unstructured":"Noyola-Mart\u00ednez N, Halhali A, Barrera D. Steroid hormones and pregnancy. Gynecol Endocrinol. 2019, 35:376-84. 10.1080\/09513590.2018.1564742","journal-title":"Gynecol Endocrinol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpobgyn.2020.09.002","article-title":"Sporadic pregnancy loss and recurrent miscarriage","volume":"69","author":"Devall AJ","year":"2020","unstructured":"Devall AJ, Coomarasamy A. Sporadic pregnancy loss and recurrent miscarriage. Best Pract Res Clin Obstet Gynaecol. 2020, 69:30-9. 10.1016\/j.bpobgyn.2020.09.002","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpobgyn.2020.06.002","article-title":"The pharmacodynamics and safety of progesterone","volume":"69","author":"Piette PC","year":"2020","unstructured":"Piette PC. The pharmacodynamics and safety of progesterone. Best Pract Res Clin Obstet Gynaecol. 2020, 69:13-29. 10.1016\/j.bpobgyn.2020.06.002","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"ref7","unstructured":"Pakistan birth rate. (2021). Accessed. May 15, 2025: https:\/\/www.indexmundi.com\/pakistan\/birth_rate.html."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00682-6","article-title":"Miscarriage matters: the epidemiological, physical, psychological, and economic costs of early pregnancy loss","volume":"397","author":"Quenby S","year":"2021","unstructured":"Quenby S, Gallos ID, Dhillon-Smith RK, et al.. Miscarriage matters: the epidemiological, physical, psychological, and economic costs of early pregnancy loss. Lancet. 2021, 397:1658-67. 10.1016\/S0140-6736(21)00682-6","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1080\/14767050802559129","article-title":"Stillbirth in developing countries: a review of causes, risk factors and prevention strategies","volume":"22","author":"McClure EM","year":"2009","unstructured":"McClure EM, Saleem S, Pasha O, Goldenberg RL. Stillbirth in developing countries: a review of causes, risk factors and prevention strategies. J Matern Fetal Neonatal Med. 2009, 22:183-90. 10.1080\/14767050802559129","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/s12978-018-0525-4","article-title":"Early pregnancy loss in Belagavi, Karnataka, India 2014-2017: a prospective population-based observational study in a low-resource setting","volume":"15","author":"Dhaded SM","year":"2018","unstructured":"Dhaded SM, Somannavar MS, Jacob JP, et al.. Early pregnancy loss in Belagavi, Karnataka, India 2014-2017: a prospective population-based observational study in a low-resource setting. Reprod Health. 2018, 15:95. 10.1186\/s12978-018-0525-4","journal-title":"Reprod Health"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12103388","article-title":"Understanding progestins: from basics to clinical applicability","volume":"12","author":"Garc\u00eda-S\u00e1enz M","year":"2023","unstructured":"Garc\u00eda-S\u00e1enz M, Ibarra-Salce R, Pozos-Varela FJ, et al.. Understanding progestins: from basics to clinical applicability. J Clin Med. 2023, 12:10.3390\/jcm12103388","journal-title":"J Clin Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2147\/IJWH.S224159","article-title":"The role of progestogens in threatened and idiopathic recurrent miscarriage","volume":"11","author":"Arab H","year":"2019","unstructured":"Arab H, Alharbi AJ, Oraif A, et al.. The role of progestogens in threatened and idiopathic recurrent miscarriage. Int J Womens Health. 2019, 11:589-96. 10.2147\/IJWH.S224159","journal-title":"Int J Womens Health"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-59452-y","article-title":"Characterisation of serum progesterone and progesterone-induced blocking factor (PIBF) levels across trimesters in healthy pregnant women","volume":"10","author":"Lim MK","year":"2020","unstructured":"Lim MK, Ku CW, Tan TC, Lee YH, Allen JC, Tan NS. Characterisation of serum progesterone and progesterone-induced blocking factor (PIBF) levels across trimesters in healthy pregnant women. Sci Rep. 2020, 10:3840. 10.1038\/s41598-020-59452-y","journal-title":"Sci Rep"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe1903069","article-title":"Progesterone for threatened abortion","volume":"380","author":"Greene MF","year":"2019","unstructured":"Greene MF. Progesterone for threatened abortion. N Engl J Med. 2019, 380:1867-8. 10.1056\/NEJMe1903069","journal-title":"N Engl J Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/jog.13909","article-title":"Efficacy of progesterone on threatened miscarriage: difference in drug types","volume":"45","author":"Wang XX","year":"2019","unstructured":"Wang XX, Luo Q, Bai WP. Efficacy of progesterone on threatened miscarriage: difference in drug types. J Obstet Gynaecol Res. 2019, 45:794-802. 10.1111\/jog.13909","journal-title":"J Obstet Gynaecol Res"},{"key":"ref16","article-title":"Utrogestan and high risk pregnancy (Article in Bulgarian)","volume":"43","author":"Marinov B","year":"2004","unstructured":"Marinov B, Petkova S, Dukovski A, et al.. Utrogestan and high risk pregnancy (Article in Bulgarian). Akush Ginekol (Sofiia). 2004, 43:22-4.","journal-title":"Akush Ginekol (Sofiia)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013792.pub2","article-title":"Progestogens for preventing miscarriage: a network meta-analysis","volume":"4","author":"Devall AJ","year":"2021","unstructured":"Devall AJ, Papadopoulou A, Podesek M, Haas DM, Price MJ, Coomarasamy A, Gallos ID. Progestogens for preventing miscarriage: a network meta-analysis. Cochrane Database Syst Rev. 2021, 4:CD013792. 10.1002\/14651858.CD013792.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3389\/frph.2023.1321284","article-title":"Restoration of serum estradiol and reduced incidence of miscarriage in patients with low serum estradiol during pregnancy: a retrospective cohort study using a multifactorial protocol including DHEA","volume":"5","author":"Boyle P","year":"2023","unstructured":"Boyle P, Andralojc K, van der Velden S, Najmabadi S, de Groot T, Turczynski C, Stanford JB. Restoration of serum estradiol and reduced incidence of miscarriage in patients with low serum estradiol during pregnancy: a retrospective cohort study using a multifactorial protocol including DHEA. Front Reprod Health. 2023, 5:1321284. 10.3389\/frph.2023.1321284","journal-title":"Front Reprod Health"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2021.04.013","article-title":"Intramuscular progesterone optimizes live birth from programmed frozen embryo transfer: a randomized clinical trial","volume":"116","author":"Devine K","year":"2021","unstructured":"Devine K, Richter KS, Jahandideh S, Widra EA, McKeeby JL. Intramuscular progesterone optimizes live birth from programmed frozen embryo transfer: a randomized clinical trial. Fertil Steril. 2021, 116:633-43. 10.1016\/j.fertnstert.2021.04.013","journal-title":"Fertil Steril"},{"key":"ref20","article-title":"Role of micronized progesterone vs dydrogestron in patients with threatened abortion","volume":"12","author":"Shaikh R","year":"2022","unstructured":"Shaikh R, Jalbani A, Lashari S, Sangi SU, Brohi S, Shaikh Q. Role of micronized progesterone vs dydrogestron in patients with threatened abortion. J Soc Obstet Gynaecol Pak. 2022, 12:262-6.","journal-title":"J Soc Obstet Gynaecol Pak"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dey306","article-title":"Oral dydrogesterone versus intravaginal micronized progesterone gel for luteal phase support in IVF: a randomized clinical trial","volume":"33","author":"Griesinger G","year":"2018","unstructured":"Griesinger G, Blockeel C, Sukhikh GT, et al.. Oral dydrogesterone versus intravaginal micronized progesterone gel for luteal phase support in IVF: a randomized clinical trial. Hum Reprod. 2018, 33:2212-21. 10.1093\/humrep\/dey306","journal-title":"Hum Reprod"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1080\/13697137.2018.1450856","article-title":"Vaginal progesterone and the vaginal first-pass effect","volume":"21","author":"Warren MP","year":"2018","unstructured":"Warren MP. Vaginal progesterone and the vaginal first-pass effect. Climacteric. 2018, 21:355-7. 10.1080\/13697137.2018.1450856","journal-title":"Climacteric"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s13224-021-01473-2","article-title":"A comparative, randomized control trial in patients of per vaginal bleeding comparing efficacy of oral dydrogesterone versus vaginal progesterone in successful pregnancy outcome for patients with recurrent pregnancy loss","volume":"71","author":"Kale AR","year":"2021","unstructured":"Kale AR, Kale AA, Yelikar K. A comparative, randomized control trial in patients of per vaginal bleeding comparing efficacy of oral dydrogesterone versus vaginal progesterone in successful pregnancy outcome for patients with recurrent pregnancy loss. J Obstet Gynaecol India. 2021, 71:591-5. 10.1007\/s13224-021-01473-2","journal-title":"J Obstet Gynaecol India"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jogoh.2020.102030","article-title":"Oral dydrogesterone vs. micronized vaginal progesterone gel for luteal phase support in frozen-thawed single blastocyst transfer in good prognosis patients","volume":"50","author":"Ozer G","year":"2021","unstructured":"Ozer G, Yuksel B, Yucel Cicek OS, Kahraman S. Oral dydrogesterone vs. micronized vaginal progesterone gel for luteal phase support in frozen-thawed single blastocyst transfer in good prognosis patients. J Gynecol Obstet Hum Reprod. 2021, 50:102030. 10.1016\/j.jogoh.2020.102030","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.7573\/dic.2021-7-1","article-title":"A review of conventional and sustained-release formulations of oral natural micronized progesterone in obstetric indications","volume":"10","author":"Wagh GN","year":"2021","unstructured":"Wagh GN, Kundavi Shankar KM, Bachani S. A review of conventional and sustained-release formulations of oral natural micronized progesterone in obstetric indications. Drugs Context. 2021, 10:10.7573\/dic.2021-7-1","journal-title":"Drugs Context"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/383355-safety-tolerability-and-pregnancy-outcomes-following-gravibinan-administration-in-women-at-risk-of-miscarriage-a-multi-institutional-retrospective-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T11:36:21Z","timestamp":1752665781000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/383355-safety-tolerability-and-pregnancy-outcomes-following-gravibinan-administration-in-women-at-risk-of-miscarriage-a-multi-institutional-retrospective-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,16]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.88063","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,7,16]]}}}